Charles Trout
Internal Medicine · Albany, NYNPI 1215929344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 347 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,751 and has fallen 54.3% since, to $801 in 2022.
Across 347 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$882
- AstraZeneca$500
- Merck$426
- Boehringer Ingelheim$398
- GSK$387
- AbbVie$362
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,148100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 67 | $882 |
| AstraZeneca | 20 | $500 |
| Merck | 32 | $426 |
| Boehringer Ingelheim | 28 | $398 |
| GSK | 27 | $387 |
| AbbVie(2 entities) | 31 | $362 |
| Pfizer | 16 | $269 |
| Johnson & Johnson | 14 | $243 |
| Novartis | 13 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $148 |
| E.r. Squibb & Sons, L.L.C. | 8 | $128 |
| Biohaven Pharmaceuticals, Inc. | 9 | $115 |
| Lilly USA, LLC | 8 | $109 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Eisai Inc. | 4 | $92 |
| Amarin Pharma, Inc. | 6 | $87 |
| Amgen | 6 | $82 |
| Currax Pharmaceuticals LLC | 6 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $77 |
| Abbott | 4 | $76 |
| Bayer | 4 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Astellas Pharma US Inc | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Esperion Therapeutics, Inc. | 3 | $40 |
| Mannkind Corporation | 2 | $25 |
| Edwards Lifesciences | 1 | $18 |
| Medtronic | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$5,148 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Albany
- Scott BeegleAlbany$1.9M
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.